SAN DIEGO, NOV. 04, 2025 (GLOBE NEWSWIRE) -- JOHNSON FISTEL, PLLP ANNOUNCES THAT A CLASS ACTION LAWSUIT HAS BEEN FILED ON BEHALF OF INVESTORS OF FLY-E GROUP, INC. (NASDAQ: FLYE). THE LAWSUIT SEEKS TO RECOVER LOSSES ON BEHALF OF INVESTORS WHO PURCHASED OR ACQUIRED THE COMPANY'S SECURITIES BETWEEN JULY 15, 2025 AND AUGUST 14, 2025, INCLUSIVE (THE “CLASS PERIOD”).
HOUSTON , NOV. 4, 2025 /PRNEWSWIRE/ -- FLOTEK INDUSTRIES, INC. ("FLOTEK" OR THE "COMPANY") (NYSE: FTK), A LEADER IN INNOVATIVE ENERGY SOLUTIONS, TODAY ANNOUNCED ITS FINANCIAL RESULTS FOR THE QUARTER AND NINE-MONTHS ENDED SEPTEMBER 30, 2025, WHICH REFLECT CONTINUED SUCCESSFUL EXECUTION OF ITS TRANSFORMATIONAL STRATEGY AND ROBUST GROWTH ACROSS ITS TWO SEGMENTS. FINANCIAL SUMMARY (IN THOUSANDS, EXCEPT 'PER SHARE' AMOUNTS) THREE MONTHS ENDED SEPTEMBER 30, NINE MONTHS ENDED SEPTEMBER 30, 2025 2024 % CHANGE 2025 2024 % CHANGE TOTAL REVENUES $ 56,031 $ 49,742 13 % $ 169,743 $ 136,267 25 % GROSS PROFIT $ 17,783 $ 9,119 95 % $ 44,639 $ 27,108 65 % NET INCOME $ 20,355 $ 2,532 704 % $ 27,503 $ 6,068 353 % DILUTED INCOME PER SHARE $ 0.53 $ 0.08 563 % $ 0.78 $ 0.20 290 % ADJUSTED EBITDA (1) $ 11,721 $ 4,840 142 % $ 28,953 $ 13,303 118 % HIGHLIGHTS: (ALL COMPARISONS VERSUS Q3 2024 UNLESS NOTED) TOTAL REVENUES INCREASED 13% DRIVEN LARGELY BY THE DATA ANALYTICS SEGMENT, AS THE MOBILE GAS CONDITIONING ASSETS ACQUIRED IN THE SECOND QUARTER OF 2025 (THE "ACQUIRED ASSETS") GENERATED $6.1 MILLION OF THIRD QUARTER 2025 REVENUE.
SAN DIEGO, NOV. 04, 2025 (GLOBE NEWSWIRE) -- JOHNSON FISTEL, PLLP, A LEADING STOCKHOLDER RIGHTS LAW FIRM, HAS INITIATED AN INVESTIGATION INTO CERTAIN BOARD MEMBERS AND EXECUTIVE OFFICERS OF METHODE ELECTRONICS, INC. (NYSE: MEI) FOR POTENTIAL BREACHES OF FIDUCIARY DUTIES AND VIOLATIONS OF FEDERAL SECURITIES LAWS. STOCK PURCHASERS BEFORE JUNE 23, 2022 HAVE RIGHTS: CURRENT STOCKHOLDERS WHO HELD THEIR METHODE ELECTRONICS STOCK BEFORE JUNE 23, 2022, ARE ENCOURAGED TO CONTACT JOHNSON FISTEL TO DISCUSS THEIR LEGAL RIGHTS IN THIS MATTER.
LOS ANGELES , NOV. 4, 2025 /PRNEWSWIRE/ -- "STRONG FAN DEMAND DROVE ANOTHER RECORD QUARTER, AS WE CONTINUE TO ATTRACT MORE FANS TO MORE SHOWS GLOBALLY. WITH THESE TAILWINDS, 2026 IS OFF TO A STRONG START WITH A DOUBLE-DIGIT INCREASE IN OUR LARGE VENUE SHOW PIPELINE AND INCREASED SELL-THROUGH LEVELS FOR THESE SHOWS.
SAN FRANCISCO--(BUSINESS WIRE)--PINTEREST, INC. (NYSE: PINS) TODAY ANNOUNCED FINANCIAL RESULTS FOR THE QUARTER ENDED SEPTEMBER 30, 2025. REVENUE WAS $1,049 MILLION, GROWING 17% YEAR OVER YEAR. ON A CONSTANT CURRENCY BASIS, REVENUE WOULD HAVE GROWN 16% YEAR OVER YEAR. GLOBAL MONTHLY ACTIVE USERS ("MAUS") INCREASED 12% YEAR OVER YEAR TO 600 MILLION. GAAP NET INCOME WAS $92 MILLION AND ADJUSTED EBITDA WAS $306 MILLION. NET CASH PROVIDED BY OPERATING ACTIVITIES WAS $322 MILLION AND FREE CASH FLOW W.
CAMPBELL, CALIF., NOV. 04, 2025 (GLOBE NEWSWIRE) -- ARTERIS, INC. (NASDAQ: AIP), A LEADING PROVIDER OF SEMICONDUCTOR SYSTEM IP FOR ACCELERATING SYSTEM-ON-CHIP (SOC) CREATION, TODAY ANNOUNCED FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025 AND PROVIDED ESTIMATED FOURTH QUARTER AND UPDATED FULL YEAR 2025 GUIDANCE.
SALT LAKE CITY, NOV. 04, 2025 (GLOBE NEWSWIRE) -- LIFEVANTAGE CORPORATION (NASDAQ:LFVN), A LEADING HEALTH AND WELLNESS COMPANY WITH PRODUCTS DESIGNED TO ACTIVATE OPTIMAL HEALTH PROCESSES AT THE CELLULAR LEVEL, TODAY ANNOUNCED THAT THE COMPANY'S BOARD OF DIRECTORS HAS APPROVED A QUARTERLY CASH DIVIDEND OF $0.045 PER SHARE OF COMMON STOCK, WHICH WILL BE PAID DECEMBER 15, 2025 TO ALL STOCKHOLDERS OF RECORD AT THE CLOSE OF BUSINESS ON DECEMBER 1, 2025.
NET INCOME OF $5.8 MILLION AND DILUTED EPS OF $0.51 PER SHARE REVENUE OF $42.0 MILLION, INCLUDING 93.8% RECURRING REVENUE COMPANY REITERATES EXPECTATION OF ADDING A NEW CUSTOMER IN 2025 ADDITIONAL TIER 1 CUSTOMER SIGNING EXPECTED IN FIRST HALF OF 2026 BRIDGEWATER, N.J., NOV. 04, 2025 (GLOBE NEWSWIRE) -- SYNCHRONOSS TECHNOLOGIES INC. (“SYNCHRONOSS” OR THE “COMPANY”) (NASDAQ: SNCR), A GLOBAL LEADER AND INNOVATOR IN PERSONAL CLOUD PLATFORMS, TODAY REPORTED FINANCIAL RESULTS FOR ITS THIRD QUARTER ENDED SEPTEMBER 30, 2025.
BOCA RATON, FL / ACCESS NEWSWIRE / NOVEMBER 4, 2025 / NEWSMAX INC. (NYSE:NMAX) ("NEWSMAX" OR THE "COMPANY") TODAY ANNOUNCED THAT MANAGEMENT, INCLUDING CEO CHRISTOPHER RUDDY, WILL ATTEND THE RBC CAPITAL MARKETS GLOBAL TECHNOLOGY, INTERNET, MEDIA & TELECOMMUNICATIONS CONFERENCE BEING HELD IN NEW YORK CITY FROM NOVEMBER 18-19, 2025. MANAGEMENT AND MR.
GREENSBORO, N.C.--(BUSINESS WIRE)--TANGER® (NYSE:SKT), A LEADING OWNER AND OPERATOR OF OUTLET AND OPEN-AIR RETAIL SHOPPING DESTINATIONS, TODAY REPORTED FINANCIAL RESULTS AND OPERATING METRICS FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2025. “THE SUCCESSFUL EXECUTION OF OUR STRATEGIC PLAN DELIVERED ANOTHER QUARTER OF STRONG FINANCIAL AND OPERATING RESULTS, CONTRIBUTING TO AN INCREASE IN OUR FULL-YEAR GUIDANCE,” SAID STEPHEN YALOF, PRESIDENT AND CHIEF EXECUTIVE OFFICER. “WE ARE SEEING ROBU.
NEWPORT BEACH, CALIF.--(BUSINESS WIRE)--CLEAN ENERGY FUELS CORP. (NASDAQ: CLNE) (“CLEAN ENERGY” OR THE “COMPANY”) TODAY ANNOUNCED ITS OPERATING RESULTS FOR THE THIRD QUARTER OF 2025. FINANCIAL HIGHLIGHTS REVENUE OF $106.1 MILLION IN Q3 2025 COMPARED TO $104.9 MILLION IN Q3 2024. NET LOSS ATTRIBUTABLE TO CLEAN ENERGY FOR Q3 2025 WAS $(23.8) MILLION, OR $(0.11) PER SHARE, ON A GAAP (AS DEFINED BELOW) BASIS, COMPARED TO $(18.2) MILLION, OR $(0.08) PER SHARE, FOR Q3 2024. ADJUSTED EBITDA (AS DEFINE.
NEW YORK--(BUSINESS WIRE)--ZETA GLOBAL REPORTS 17TH STRAIGHT “BEAT AND RAISE” QUARTER.
IRVINE, CALIF.--(BUSINESS WIRE)--MASIMO CORPORATION (NASDAQ: MASI) TODAY ANNOUNCED ITS FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 27, 2025. THIRD QUARTER 2025 RESULTS FROM CONTINUING OPERATIONS(1): GAAP REVENUE OF $371.5 MILLION, REPRESENTING 8.2% GROWTH ON A REPORTED BASIS; NON-GAAP REVENUE OF $371.2 MILLION, REPRESENTING 7.6% GROWTH ON A CONSTANT CURRENCY BASIS(2); GAAP NET INCOME PER DILUTED SHARE OF $0.99; AND NON-GAAP NET INCOME PER DILUTED SHARE(2) OF $1.32, REPRESENTING 38%.
FOSTER CITY, CALIF.--(BUSINESS WIRE)-- #GILD--GILEAD SCIENCES, INC. (NASDAQ: GILD) ANNOUNCED TODAY THAT ITS EXECUTIVES WILL BE SPEAKING AT THE FOLLOWING INVESTOR CONFERENCES: UBS GLOBAL HEALTHCARE CONFERENCE ON MONDAY, NOVEMBER 10 AT 11:00 AM EASTERN TIME JEFFERIES GLOBAL HEALTHCARE CONFERENCE IN LONDON ON WEDNESDAY, NOVEMBER 19 AT 2:00 PM GREENWICH MEAN TIME CITI'S GLOBAL HEALTHCARE CONFERENCE ON TUESDAY, DECEMBER 2 AT 11:15 AM EASTERN TIME ANNUAL EVERCORE HEALTHCARE CONFERENCE ON WEDNESDAY, DECEMBER.
NEWTON, MASS.--(BUSINESS WIRE)-- #AIINWORKPLACE--AI IS TRANSFORMING JOBS—EDASSIST'S NEW DATA REPORT REVEALS URGENT DEMAND FOR UPSKILLING, EMPLOYER SUPPORT, AND AFFORDABLE EDUCATION NATIONWIDE.
SOUTH SAN FRANCISCO, CALIF.--(BUSINESS WIRE)--VERACYTE, INC. (NASDAQ: VCYT), A LEADING CANCER DIAGNOSTICS COMPANY, TODAY ANNOUNCED FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025. “WE DELIVERED ANOTHER OUTSTANDING QUARTER OF TESTING REVENUE GROWTH AND ADJUSTED EBITDA MARGIN EXPANSION, ENABLING US TO RAISE BOTH OUR REVENUE AND PROFITABILITY GUIDANCE,” SAID MARC STAPLEY, VERACYTE'S CHIEF EXECUTIVE OFFICER. “WE CONTINUE TO ADVANCE OUR MISSION OF TRANSFORMING CANCER CARE BY GENERAT.
REDWOOD CITY, CALIF.--(BUSINESS WIRE)--CORCEPT THERAPEUTICS INCORPORATED (NASDAQ: CORT), A COMMERCIAL-STAGE COMPANY ENGAGED IN THE DISCOVERY AND DEVELOPMENT OF MEDICATIONS TO TREAT SEVERE ENDOCRINOLOGIC, ONCOLOGIC, METABOLIC AND NEUROLOGIC DISORDERS BY MODULATING THE EFFECTS OF THE HORMONE CORTISOL, TODAY REPORTED ITS RESULTS FOR THE QUARTER ENDED SEPTEMBER 30, 2025. FINANCIAL RESULTS “THE THIRD QUARTER MARKED ANOTHER PERIOD OF ROBUST GROWTH IN OUR HYPERCORTISOLISM BUSINESS. ONCE AGAIN, WE HAD.
MOUNTAIN VIEW, CALIF.--(BUSINESS WIRE)--NEUROPACE, INC. (NASDAQ: NPCE), A MEDICAL DEVICE COMPANY FOCUSED ON TRANSFORMING THE LIVES OF PEOPLE LIVING WITH EPILEPSY, TODAY REPORTED FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025, AND PROVIDED A CORPORATE UPDATE. THIRD QUARTER 2025 FINANCIAL HIGHLIGHTS TOTAL REVENUE OF $27.4 MILLION, REPRESENTING GROWTH OF 30% COMPARED TO THE THIRD QUARTER OF 2024 RNS® SYSTEM REVENUE OF $22.6 MILLION, REPRESENTING GROWTH OF 31% COMPARED TO THE THIR.
MENLO PARK, CALIF., NOV. 04, 2025 (GLOBE NEWSWIRE) -- SIGHT SCIENCES, INC. (NASDAQ: SGHT) (SIGHT SCIENCES OR THE COMPANY), AN EYECARE TECHNOLOGY COMPANY FOCUSED ON DEVELOPING AND COMMERCIALIZING INNOVATIVE, INTERVENTIONAL TECHNOLOGIES INTENDED TO TRANSFORM CARE AND IMPROVE PATIENTS' LIVES, TODAY ANNOUNCED PLANS TO PRESENT AT THE UPCOMING STIFEL 2025 HEALTHCARE CONFERENCE AND THE PIPER SANDLER 37TH ANNUAL HEALTHCARE CONFERENCE, BOTH IN NEW YORK, NY.
OVER 3 MILLION PAID SUBSCRIBERS, UP 6% OVER Q3 2024 Q3 2025 REVENUE OF $170.4 MILLION, UP 2% COMPARED TO Q3 2024 NET INCOME OF $20.5 MILLION , UP 79% COMPARED TO Q3 2024 RECURRING SEMI-ANNUAL DIVIDEND OF $0.10 PER SHARE TO BE PAID IN JANUARY 2026 SOUTH JORDAN, UTAH, NOV. 04, 2025 (GLOBE NEWSWIRE) -- CRICUT, INC. (“CRICUT”) (NASDAQ: CRCT), THE CREATIVE TECHNOLOGY COMPANY THAT HAS BROUGHT A CONNECTED PLATFORM FOR MAKING TO MILLIONS OF USERS WORLDWIDE, TODAY ANNOUNCED FINANCIAL RESULTS FOR ITS THIRD QUARTER ENDED SEPTEMBER 30, 2025. “WE ARE PLEASED WITH OUR SECOND CONSECUTIVE QUARTER OF SALES GROWTH IN Q3.
INITIAL ROLLOUT TO INCLUDE 188 LOCATIONS WITH ADDITIONAL EXPANSIONS PLANNED INITIAL ROLLOUT TO INCLUDE 188 LOCATIONS WITH ADDITIONAL EXPANSIONS PLANNED
RECORD QUARTERLY REVENUE OF $230.6 MILLION, UP 20% QOQ AND 104% YOY STRONG Q3 REVENUE GROWTH DRIVEN BY NEW AI PLATFORM RAMPS FEATURING MULTIPLE PRODUCT FAMILIES SCORPIO FABRIC SWITCH DESIGN WINS EXPAND TO SEVERAL PLATFORMS AT MULTIPLE HYPERSCALER CUSTOMERS SAN JOSE, CALIF., NOV. 04, 2025 (GLOBE NEWSWIRE) -- ASTERA LABS, INC. (NASDAQ: ALAB), A LEADER IN SEMICONDUCTOR-BASED CONNECTIVITY SOLUTIONS FOR RACK-SCALE AI INFRASTRUCTURE, TODAY ANNOUNCED PRELIMINARY FINANCIAL RESULTS FOR THE THIRD QUARTER OF FISCAL YEAR 2025, ENDED SEPTEMBER 30, 2025.
DELIVERED QUARTERLY XDEMVY ® NET SALES OF APPROXIMATELY $119 MILLION, UP APPROXIMATELY 147% YEAR-OVER-YEAR
SUNNYVALE, CALIF., NOV. 04, 2025 (GLOBE NEWSWIRE) -- CERIBELL, INC. (NASDAQ: CBLL) (“CERIBELL”), A MEDICAL TECHNOLOGY COMPANY FOCUSED ON TRANSFORMING THE DIAGNOSIS AND MANAGEMENT OF PATIENTS WITH SERIOUS NEUROLOGICAL CONDITIONS, TODAY REPORTED FINANCIAL RESULTS FOR THE QUARTER ENDED SEPTEMBER 30, 2025.
LATHAM OUTPERFORMS THE U.S. IN-GROUND POOL MARKET WITH STRONG THIRD QUARTER RESULTS NET SALES GROWTH OF 7.6%, INCLUDING ORGANIC GROWTH OF 4.7% GROSS MARGIN EXPANDED BY 300 BASIS POINTS THIRD QUARTER 2025 FINANCIAL HIGHLIGHTS: NET SALES OF $161.9 MILLION UP 7.6% NET INCOME OF $8.1 MILLION UP 37.7% / EARNINGS PER DILUTED SHARE OF $0.07 VS. $0.05 IN PRIOR YEAR ADJUSTED EBITDA OF $38.3 MILLION UP 28.5% REACHING 23.7% OF NET SALES NINE MONTHS 2025 FINANCIAL HIGHLIGHTS: NET SALES OF $446.0 MILLION UP 5.9% NET INCOME OF $18.1 MILLION UP 60.3% / EARNINGS PER DILUTED SHARE OF $0.15 VS.
FOSTER CITY, CALIF., NOV. 04, 2025 (GLOBE NEWSWIRE) -- TERNS PHARMACEUTICALS, INC. (“TERNS” OR THE “COMPANY”) (NASDAQ: TERN), A CLINICAL-STAGE ONCOLOGY COMPANY, TODAY ANNOUNCED THAT IT HAS GRANTED AS OF NOVEMBER 1, 2025 EQUITY INDUCEMENT AWARDS TO TWO NEW EMPLOYEES UNDER THE TERMS OF THE 2022 EMPLOYMENT INDUCEMENT AWARD PLAN, AS AMENDED. THE EQUITY AWARDS WERE APPROVED BY THE COMPENSATION COMMITTEE OF THE COMPANY'S BOARD OF DIRECTORS IN ACCORDANCE WITH NASDAQ LISTING RULE 5635(C)(4) AND WERE MADE AS A MATERIAL INDUCEMENT TO THE EMPLOYEES' ACCEPTANCE OF EMPLOYMENT WITH TERNS.
FINAL DATA FROM VAX-24 INFANT PHASE 2 DOSE-FINDING STUDY CONSISTENT WITH PREVIOUSLY REPORTED POSITIVE INTERIM DATA; PROVIDE ADDITIONAL EVIDENCE SUPPORTING HIGHER VAX-31 DOSES BEING EVALUATED IN ONGOING INFANT PHASE 2 STUDY
SAN DIEGO, NOV. 04, 2025 (GLOBE NEWSWIRE) -- KRATOS DEFENSE & SECURITY SOLUTIONS, INC., A TECHNOLOGY COMPANY IN DEFENSE, NATIONAL SECURITY, AND GLOBAL MARKETS, ANNOUNCED TODAY THAT IT HAS SIGNED A DEFINITIVE AGREEMENT TO ACQUIRE 100 PERCENT OF THE ORDINARY SHARES OF ORBIT TECHNOLOGIES LTD (ORBI.TA) FOR $356.3 MILLION, WHICH IS EXPECTED TO BE FUNDED VIA CASH ON KRATOS' BALANCE SHEET.
PORTLAND, MAINE, NOV. 04, 2025 (GLOBE NEWSWIRE) -- IMMUCELL CORPORATION (NASDAQ: ICCC) (“IMMUCELL” OR THE “COMPANY”), A GROWING ANIMAL HEALTH COMPANY THAT DEVELOPS, MANUFACTURES AND MARKETS SCIENTIFICALLY PROVEN AND PRACTICAL PRODUCTS THAT IMPROVE THE HEALTH AND PRODUCTIVITY OF DAIRY AND BEEF CATTLE, TODAY ANNOUNCED THE START DATE OF ITS NEW CEO AND RELATED BOARD CHANGES.
WARSAW, IND., NOV. 04, 2025 (GLOBE NEWSWIRE) -- ORTHOPEDIATRICS CORP. (“ORTHOPEDIATRICS” OR THE “COMPANY”) (NASDAQ: KIDS), A COMPANY FOCUSED EXCLUSIVELY ON ADVANCING THE FIELD OF PEDIATRIC ORTHOPEDICS, A COMPANY FOCUSED EXCLUSIVELY ON ADVANCING THE FIELD OF PEDIATRIC ORTHOPEDICS, TODAY ANNOUNCED THAT IT WILL PARTICIPATE IN THREE UPCOMING INVESTOR CONFERENCES.
RESTON, VA., NOV. 04, 2025 (GLOBE NEWSWIRE) -- COMSCORE, INC. (NASDAQ: SCOR), A TRUSTED PARTNER FOR PLANNING, TRANSACTING AND EVALUATING MEDIA ACROSS PLATFORMS, TODAY REPORTED FINANCIAL RESULTS FOR THE QUARTER ENDED SEPTEMBER 30, 2025.
ISS AND GLASS LEWIS BOTH RECOGNIZE COMPELLING VALUE TRANSACTION DELIVERS TO WORKHORSE SHAREHOLDERS VISIT VOTEWKHS.COM FOR INFORMATION ON HOW TO VOTE CINCINNATI, NOV. 04, 2025 (GLOBE NEWSWIRE) -- WORKHORSE GROUP, INC. (NASDAQ: WKHS) (“WORKHORSE” OR “THE COMPANY”), AN AMERICAN TECHNOLOGY COMPANY FOCUSED ON PIONEERING THE TRANSITION TO ZERO-EMISSION COMMERCIAL VEHICLES, TODAY ANNOUNCED THAT LEADING INDEPENDENT PROXY ADVISORY FIRMS INSTITUTIONAL SHAREHOLDER SERVICES (“ISS”) AND GLASS LEWIS & CO. (“GLASS LEWIS”) RECOMMEND THAT WORKHORSE SHAREHOLDERS VOTE FOR THE COMPANY'S TRANSACTION WITH MOTIV ELECTRIC TRUCKS (“MOTIV”) AHEAD OF THE UPCOMING 2025 ANNUAL GENERAL MEETING OF SHAREHOLDERS (THE “ANNUAL MEETING”) ON NOVEMBER 12, 2025. RICK DAUCH, CEO OF WORKHORSE, SAID, “WE ARE PLEASED THAT ISS AND GLASS LEWIS RECOGNIZE THAT OUR TRANSACTION WITH MOTIV REPRESENTS A SIGNIFICANT MILESTONE FOR OUR COMPANY AND GIVES OUR SHAREHOLDERS THE OPPORTUNITY TO PARTICIPATE IN THE POTENTIAL UPSIDE OF A LEADER IN THE MEDIUM-DUTY EV COMMERCIAL VEHICLE MARKET.
BOULDER, COLO., NOV. 04, 2025 (GLOBE NEWSWIRE) -- ONKURE THERAPEUTICS, INC. (NASDAQ: OKUR), A CLINICAL-STAGE BIOPHARMACEUTICAL COMPANY FOCUSED ON THE DEVELOPMENT OF NOVEL PRECISION MEDICINES, TODAY ANNOUNCED THAT NICHOALS SACCOMANO, PH.D., PRESIDENT AND CHIEF EXECUTIVE OFFICER, WILL PRESENT AND BE AVAILABLE FOR ONE-ON-ONE INVESTOR MEETINGS AT THE FOLLOWING INVESTOR CONFERENCES:
SOUTH SAN FRANCISCO, CALIF., NOV. 04, 2025 (GLOBE NEWSWIRE) -- STANDARD BIOTOOLS INC. (NASDAQ: LAB) (THE “COMPANY” OR “STANDARD BIOTOOLS”) TODAY ANNOUNCED FINANCIAL RESULTS FOR THE QUARTER ENDED SEPTEMBER 30, 2025.
REPORTED POSITIVE INTERIM PHASE 1 RESULTS FOR SPY003, A NEXT-GENERATION ANTI-IL-23 ANTIBODY, DEMONSTRATING THE MOLECULE WAS WELL-TOLERATED AND EXHIBITED AN ~85-DAY HALF-LIFE SUPPORTING QUARTERLY OR TWICE ANNUAL MAINTENANCE DOSING
CAMPBELL, CALIF., NOV. 04, 2025 (GLOBE NEWSWIRE) -- ARTERIS, INC. (NASDAQ: AIP), A LEADING PROVIDER OF SYSTEM IP FOR ACCELERATING SEMICONDUCTOR CREATION IN THE AI ERA, TODAY ANNOUNCED THAT ALTERA HAS LICENSED ARTERIS' BROAD PRODUCT PORTFOLIO FOR THE DEVELOPMENT OF NEXT-GENERATION FPGA AND SOC FPGA SOLUTIONS.
NEW YORK, NOV. 04, 2025 (GLOBE NEWSWIRE) -- PROTARA THERAPEUTICS, INC. (NASDAQ: TARA), A CLINICAL-STAGE COMPANY DEVELOPING TRANSFORMATIVE THERAPIES FOR THE TREATMENT OF CANCER AND RARE DISEASES, TODAY ANNOUNCED THAT IT HAS BEEN NAMED A BIOSPACE 2026 BEST PLACE TO WORK. “PROTARA IS THRILLED TO BE RECOGNIZED AS ONE OF THE MOST SOUGHT-AFTER BIOTECH EMPLOYERS IN THE LIFE SCIENCES COMMUNITY,” SAID JESSE SHEFFERMAN, CHIEF EXECUTIVE OFFICER OF PROTARA THERAPEUTICS.
COVINGTON, LA., NOV. 04, 2025 (GLOBE NEWSWIRE) -- POOL CORPORATION (NASDAQ: POOL) ANNOUNCED TODAY THAT IT WILL PARTICIPATE IN THE FOLLOWING INVESTOR EVENTS IN NOVEMBER 2025: NOVEMBER 11, 2025 – BAIRD 2025 GLOBAL INDUSTRIAL CONFERENCE NOVEMBER 18, 2025 – STEPHENS ANNUAL INVESTMENT CONFERENCE INVESTOR-RELATED MATERIALS AND COMPANY INFORMATION ARE AVAILABLE ON THE INVESTOR RELATIONS SECTION OF POOLCORP'S WEBSITE.
THIRD QUARTER SALES WERE $151.5 MILLION NET LOSS ATTRIBUTABLE TO DMC WAS $3.1 MILLION ADJUSTED NET LOSS ATTRIBUTABLE TO DMC* WAS $1.6 MILLION, OR $(0.08) PER DILUTED SHARE ADJUSTED EBITDA ATTRIBUTABLE TO DMC* WAS $8.6 MILLION, WHILE TOTAL ADJUSTED EBITDA, INCLUSIVE OF NON-CONTROLLING INTEREST (NCI), WAS $12.0 MILLION NET DEBT* REDUCED TO $30.1 MILLION RECORD ORDER AT NOBELCLAD DRIVES BACKLOG RECOVERY BROOMFIELD, COLO., NOV. 04, 2025 (GLOBE NEWSWIRE) -- DMC GLOBAL INC. (NASDAQ: BOOM) TODAY REPORTED FINANCIAL RESULTS FOR ITS THIRD QUARTER ENDED SEPTEMBER 30, 2025.
SALT LAKE CITY, NOV. 04, 2025 (GLOBE NEWSWIRE) -- LIFEVANTAGE CORPORATION (NASDAQ: LFVN), A LEADING HEALTH AND WELLNESS COMPANY WITH PRODUCTS DESIGNED TO ACTIVATE OPTIMAL HEALTH PROCESSES AT THE CELLULAR LEVEL, TODAY REPORTED FINANCIAL RESULTS FOR ITS FIRST FISCAL QUARTER ENDED SEPTEMBER 30, 2025. FIRST QUARTER FISCAL 2026 SUMMARY*: REVENUE WAS $47.6 MILLION, AN INCREASE OF 0.7% FROM THE PRIOR YEAR PERIOD.
REDWOOD CITY, CALIF., NOV. 04, 2025 (GLOBE NEWSWIRE) -- REVOLUTION MEDICINES, INC. (NASDAQ: RVMD), A LATE-STAGE CLINICAL ONCOLOGY COMPANY DEVELOPING TARGETED THERAPIES FOR PATIENTS WITH RAS-ADDICTED CANCERS, TODAY ANNOUNCED THAT MARK A.
MIAMI, NOV. 04, 2025 (GLOBE NEWSWIRE) -- PENNANTPARK INVESTMENT CORPORATION (THE "COMPANY") (NYSE: PNNT) DECLARES ITS MONTHLY DISTRIBUTION FOR NOVEMBER 2025 OF $0.08 PER SHARE, PAYABLE ON DECEMBER 1, 2025 TO STOCKHOLDERS OF RECORD AS OF NOVEMBER 17, 2025. THE DISTRIBUTION IS EXPECTED TO BE PAID FROM TAXABLE NET INVESTMENT INCOME.
MONTREAL AND CHARLOTTE, N.C., NOV. 04, 2025 (GLOBE NEWSWIRE) -- MILESTONE PHARMACEUTICALS INC. (NASDAQ: MIST) (THE “COMPANY” OR “MILESTONE”), TODAY ANNOUNCED THAT THE COMPANY GRANTED EQUITY AWARDS, IN THE FORM OF A TOTAL OF 65,000 OPTIONS (THE “OPTIONS”) TO PURCHASE THE COMPANY'S COMMON SHARES, PURSUANT TO THE COMPANY'S 2021 INDUCEMENT PLAN (THE “PLAN”), PREVIOUSLY APPROVED BY THE COMPANY'S COMPENSATION COMMITTEE AND THE BOARD OF DIRECTORS, AS A MATERIAL INDUCEMENT TO THE HIRING OF A NEW EMPLOYEE.
CHARLESTOWN, MASS., NOV. 04, 2025 (GLOBE NEWSWIRE) -- SOLID BIOSCIENCES INC. (NASDAQ: SLDB) (THE “COMPANY”), A LIFE SCIENCES COMPANY DEVELOPING PRECISION GENETIC MEDICINES FOR NEUROMUSCULAR AND CARDIAC DISEASES, TODAY ANNOUNCED GRANTS OF 26,550 RESTRICTED STOCK UNITS (“RSUS”) TO TWO NEWLY HIRED EMPLOYEES.
Q1 2026 RECURRING & OTHER REVENUE OF $378.9 MILLION, UP 14% YEAR-OVER-YEAR Q1 2026 TOTAL REVENUE OF $408.2 MILLION, UP 12% YEAR-OVER-YEAR REPURCHASED $200 MILLION OR 1.2 MILLION SHARES IN Q1 FISCAL YEAR 2026; $500 MILLION OR 3.0 MILLION SHARES REPURCHASED SINCE MAY 2024 ANNOUNCING UPDATED LONG-TERM FINANCIAL TARGETS, INCLUDING INCREASED ADJUSTED EBITDA AND FREE CASH FLOW MARGIN TARGETS SCHAUMBURG, ILL., NOV. 04, 2025 (GLOBE NEWSWIRE) -- PAYLOCITY HOLDING CORPORATION (NASDAQ: PCTY), A LEADING PROVIDER OF CLOUD-BASED HR, FINANCE, AND IT SOLUTIONS, TODAY ANNOUNCED FINANCIAL RESULTS FOR THE FIRST QUARTER OF FISCAL YEAR 2026, WHICH ENDED SEPTEMBER 30, 2025.
DENVER, NOV. 04, 2025 (GLOBE NEWSWIRE) -- INSPIRATO INCORPORATED (“INSPIRATO” OR THE “COMPANY”) (NASDAQ: ISPO), THE PREMIER LUXURY VACATION CLUB AND PROPERTY TECHNOLOGY COMPANY, TODAY REPORTED RESULTS FOR THE THIRD QUARTER (“Q3 2025”) ENDED SEPTEMBER 30, 2025. Q3 2025 HIGHLIGHTS: NET LOSS OF $4.5 MILLION AND ADJUSTED EBITDA OF NEGATIVE $0.1 MILLION, REPRESENTING A $3.3 MILLION OR 97% YEAR-OVER-YEAR ADJUSTED EBITDA IMPROVEMENT.
- INCREASED 2025 AFFO GUIDANCE $0.06 TO $1.30 - $1.32 PER DILUTED SHARE - - AMENDED, EXTENDED, AND EXPANDED UNSECURED CREDIT FACILITIES TO $440 MILLION - - U.S. POSTAL SERVICE OPERATIONS NOT AFFECTED BY GOVERNMENT SHUTDOWN - - ACQUIRED 47 USPS PROPERTIES FOR $42.3 MILLION AT A WEIGHTED AVERAGE CAPITALIZATION RATE OF 7.7% - - RAISED $26.0 MILLION FROM ATM PROGRAM DURING Q3 TO FUND ACQUISITIONS - CEDARHURST, NEW YORK, NOV. 04, 2025 (GLOBE NEWSWIRE) -- POSTAL REALTY TRUST, INC. (NYSE: PSTL) (THE “COMPANY”), AN INTERNALLY MANAGED REAL ESTATE INVESTMENT TRUST THAT OWNS AND MANAGES OVER 2,200 PROPERTIES LEASED PRIMARILY TO THE UNITED STATES POSTAL SERVICE (THE “USPS”), RANGING FROM LAST-MILE POST OFFICES TO INDUSTRIAL FACILITIES, TODAY ANNOUNCED RESULTS FOR THE QUARTER ENDED SEPTEMBER 30, 2025. HIGHLIGHTS FOR THE QUARTER ENDED SEPTEMBER 30, 2025 24% GROWTH IN REVENUES FROM THIRD QUARTER 2024 TO THIRD QUARTER 2025 NET INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS OF $3.8 MILLION, OR $0.13 PER DILUTED SHARE FUNDS FROM OPERATIONS ("FFO") OF $11.0 MILLION, OR $0.34 PER DILUTED SHARE ADJUSTED FUNDS FROM OPERATIONS ("AFFO") OF $10.8 MILLION, OR $0.33 PER DILUTED SHARE ACQUIRED 47 USPS PROPERTIES FOR $42.3 MILLION, EXCLUDING CLOSING COSTS, AT A WEIGHTED AVERAGE CAPITALIZATION RATE OF 7.7% SUBSEQUENT TO QUARTER END, THE COMPANY ANNOUNCED A QUARTERLY DIVIDEND OF $0.2425 PER SHARE "WE ARE PLEASED WITH OUR STRONG THIRD QUARTER RESULTS; WE ARE INCREASING OUR AFFO PER SHARE GUIDANCE FOR THE YEAR BY $0.06, DRIVEN BY STRENGTH IN OUR PROGRAMMATIC LEASING WITH THE U.S. POSTAL SERVICE AND OPERATING EFFICIENCIES," SAID ANDREW SPODEK, CHIEF EXECUTIVE OFFICER.
STRONG PORTFOLIO MOMENTUM CONTINUES TO BE DRIVEN BY AI AND AI INFRASTRUCTURE INVESTMENTS NET ASSET VALUE OF $9.23 PER SHARE AS OF SEPTEMBER 30, 2025 BOARD OF DIRECTORS DECLARES $0.25 PER SHARE CASH DIVIDEND NEW YORK, NOV. 04, 2025 (GLOBE NEWSWIRE) -- SURO CAPITAL CORP. (“SURO CAPITAL”, THE “COMPANY”, “WE”, “US”, AND “OUR”) (NASDAQ: SSSS ) TODAY ANNOUNCED ITS FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025. NET ASSETS TOTALED APPROXIMATELY $231.8 MILLION, OR $9.23 PER SHARE, AT SEPTEMBER 30, 2025, AS COMPARED TO $9.18 PER SHARE ($8.93 PER SHARE DIVIDEND-ADJUSTED), AT JUNE 30, 2025 AND $6.73 PER SHARE ($6.48 PER SHARE DIVIDEND-ADJUSTED) AT SEPTEMBER 30, 2024.
STAMFORD, CONNECTICUT--(NEWSFILE CORP. - NOVEMBER 4, 2025) - SPHERE 3D CORP. (NASDAQ: ANY) (“SPHERE 3D” OR THE “COMPANY”), A BITCOIN MINING COMPANY, TODAY REPORTED FINANCIAL RESULTS FOR THE THIRD QUARTER OF FISCAL YEAR 2025 ENDED SEPTEMBER 30, 2025. COMMENTS FROM SPHERE 3D LEADERSHIP “THIS QUARTER REFLECTS CONTINUED PROGRESS IN STRENGTHENING THE FOUNDATION OF OUR BUSINESS,” SAID KURT KALBFLEISCH, INTERIM CEO OF SPHERE 3D, “WE'VE TAKEN DELIBERATE STEPS TO POSITION THE COMPANY FOR DURABLE, LONG-TERM GROWTH, SIMPLIFYING OUR STRUCTURE AND ENHANCING FLEXIBILITY.
COLUMBUS, GA. , NOV. 4, 2025 /PRNEWSWIRE/ -- NOVEMBER 4, 2025 - AFLAC INCORPORATED (NYSE: AFL) TODAY REPORTED ITS THIRD QUARTER RESULTS.
BURLINGTON, MASS. , NOV. 4, 2025 /PRNEWSWIRE/ -- AZENTA, INC. (NASDAQ: AZTA) TODAY ANNOUNCED A STRATEGIC PARTNERSHIP WITH THE PRECEDE FOUNDATION, AN INTERNATIONAL, MULTI-INSTITUTIONAL COLLABORATIVE FOCUSED ON EARLY DETECTION AND PREVENTION OF PANCREATIC CANCER.
INVESTMENT FROM TOP-TIER INSTITUTIONAL INVESTORS ADVANCES CANAAN'S MISSION TO BUILD NEXT-GENERATION BITCOIN AND HIGH-PERFORMANCE COMPUTING INFRASTRUCTURE STRAIGHT EQUITY INVESTMENT REFLECTS CANAAN'S STRONG FUNDAMENTALS AND DISCIPLINED GROWTH APPROACH SINGAPORE , NOV. 4, 2025 /PRNEWSWIRE/ -- CANAAN INC. (NASDAQ: CAN) ("CANAAN" OR THE "COMPANY"), AN INNOVATOR IN CRYPTO MINING, TODAY ANNOUNCED THAT BH DIGITAL, A DIVISION OF BREVAN HOWARD, GALAXY DIGITAL, AND WEISS ASSET MANAGEMENT (IN ALPHABETICAL ORDER) MADE A STRATEGIC INVESTMENT TOTALING US$72 MILLION IN CANAAN THROUGH THE PURCHASE OF AMERICAN DEPOSITARY SHARES ("ADSS"), EACH REPRESENTING 15 CLASS A ORDINARY SHARES OF THE COMPANY. NO WARRANTS, OPTIONS, OR OTHER DERIVATIVE INSTRUMENTS WERE ISSUED AS PART OF THIS TRANSACTION.
HOUSTON , NOV. 4, 2025 /PRNEWSWIRE/ -- CHORD ENERGY CORPORATION (NASDAQ: CHRD) ("CHORD", "CHORD ENERGY" OR THE "COMPANY") TODAY REPORTED FINANCIAL AND OPERATING RESULTS FOR THE THIRD QUARTER 2025. KEY TAKEAWAYS AND UPDATES: STRONG EXECUTION: EFFICIENT EXECUTION AND STRONG ASSET PERFORMANCE IN 3Q25 DELIVERED OIL VOLUMES ABOVE MIDPOINT OF GUIDANCE, WITH E&P AND OTHER CAPEX BELOW MIDPOINT OF GUIDANCE; UPDATED FY25 OUTLOOK: RAISED OIL VOLUME GUIDANCE AND MAINTAINED CAPEX GUIDANCE EXCLUDING XTO IMPACTS; 4-MILE LATERAL UPDATE: TIL'D THREE ADDITIONAL 4-MILE LATERALS SINCE AUGUST.
THIRD QUARTER REVENUE INCREASED 15% YEAR-OVER-YEAR TO $44.2 MILLION COMMERCIAL CELL & GENE THERAPY REVENUE INCREASED 36% YEAR-OVER-YEAR TO $8.3 MILLION LIFE SCIENCES SERVICES REVENUE GREW 16% YEAR-OVER-YEAR, INCLUDING A 21% RISE IN BIOSTORAGE/BIOSERVICES REVENUE LIFE SCIENCES PRODUCTS REVENUE GREW 15% YEAR-OVER-YEAR COMPANY UPDATES FULL YEAR 2025 REVENUE GUIDANCE OF $170 TO $174 MILLION NASHVILLE, TENN. , NOV. 4, 2025 /PRNEWSWIRE/ -- CRYOPORT, INC. (NASDAQ: CYRX) ("CRYOPORT" OR THE "COMPANY"), A LEADING GLOBAL PROVIDER OF TEMPERATURE-CONTROLLED SUPPLY CHAIN SOLUTIONS FOR THE LIFE SCIENCES, TODAY ANNOUNCED FINANCIAL RESULTS FOR ITS THIRD QUARTER (Q3) AND FIRST NINE MONTHS (9M) OF 2025.
SECOND QUARTER REVENUE TOTALED $140.4 MILLION, REPRESENTING YEAR-OVER-YEAR GROWTH OF 18% SECOND QUARTER GAAP NET LOSS OF $21.4 MILLION AND GAAP EPS OF ($0.20); SECOND QUARTER NON-GAAP ADJUSTED NET INCOME1 OF $16.5 MILLION AND NON-GAAP ADJUSTED EPS1 OF $0.15 SECOND QUARTER NON-GAAP ADJUSTED EBITDA2 TOTALED $27.2 MILLION, REPRESENTING YEAR-OVER-YEAR GROWTH OF 78% AUSTIN, TEXAS , NOV. 4, 2025 /PRNEWSWIRE/ -- DIGITAL TURBINE, INC. (NASDAQ: APPS) ANNOUNCED FINANCIAL RESULTS FOR THE FISCAL SECOND QUARTER ENDED SEPTEMBER 30, 2025. RECENT FINANCIAL HIGHLIGHTS: FISCAL SECOND QUARTER OF 2026 REVENUE TOTALED $140.4 MILLION, REPRESENTING AN INCREASE OF 18% YEAR-OVER-YEAR AS COMPARED TO THE FISCAL SECOND QUARTER OF 2025.
LOS ANGELES , NOV. 4, 2025 /PRNEWSWIRE/ -- ISPIRE TECHNOLOGY INC. ("ISPIRE" OR THE "COMPANY") (NASDAQ: ISPR), A TRAILBLAZER IN VAPING TECHNOLOGY AND PRECISION DOSING, ANNOUNCED TODAY THAT IT WILL HOST ITS EARNINGS CONFERENCE CALL AT 8:00 AM ET ON THURSDAY, NOVEMBER 6, 2025, TO DISCUSS THE COMPANY'S FINANCIAL RESULTS FOR ITS FISCAL FIRST QUARTER ENDED SEPTEMBER 30, 2025. TO LISTEN TO THE CONFERENCE CALL, PLEASE DIAL IN USING THE INFORMATION BELOW.
3Q25 EPS OF $4.24 VERSUS $5.89 IN 3Q24 3Q25 NET INCOME OF $134.7 MILLION VERSUS $199.1 MILLION IN 3Q24 3Q25 CONSOLIDATED OPERATING INCOME OF $161.0 MILLION VERSUS $242.3 MILLION IN 3Q24 3Q25 EBITDA OF $212.3 MILLION VERSUS $289.4 MILLION IN 3Q24 REPURCHASED APPROXIMATELY 0.6 MILLION SHARES IN 3Q25 4Q25 CONSOLIDATED OPERATING INCOME EXPECTED TO BE APPROXIMATELY 30% LOWER THAN 4Q24 HONOLULU , NOV. 4, 2025 /PRNEWSWIRE/ -- MATSON, INC. ("MATSON" OR THE "COMPANY") (NYSE: MATX), A LEADING U.S. CARRIER IN THE PACIFIC, TODAY REPORTED NET INCOME OF $134.7 MILLION, OR $4.24 PER DILUTED SHARE, FOR THE QUARTER ENDED SEPTEMBER 30, 2025. NET INCOME FOR THE QUARTER ENDED SEPTEMBER 30, 2024 WAS $199.1 MILLION, OR $5.89 PER DILUTED SHARE.
LOS ANGELES , NOV. 4, 2025 /PRNEWSWIRE/ -- MERCURY GENERAL CORPORATION (NYSE: MCY) REPORTED TODAY FOR THE THIRD QUARTER OF 2025: CONSOLIDATED HIGHLIGHTS THREE MONTHS ENDED SEPTEMBER 30, CHANGE NINE MONTHS ENDED SEPTEMBER 30, CHANGE 2025 2024 $ % 2025 2024 $ % (000'S EXCEPT PER-SHARE AMOUNTS AND RATIOS) NET PREMIUMS EARNED (2) $ 1,410,400 $ 1,320,652 $ 89,748 6.8 $ 4,060,208 $ 3,723,355 $ 336,853 9.0 NET PREMIUMS WRITTEN (1) (2) $ 1,498,861 $ 1,422,933 $ 75,928 5.3 $ 4,294,048 $ 4,063,377 $ 230,671 5.7 NET REALIZED INVESTMENT GAINS, NET OF TAX (3) $ 66,716 $ 90,412 $ (23,696) (26.2) $ 103,688 $ 122,873 $ (19,185) (15.6) NET INCOME $ 280,403 $ 230,856 $ 49,547 21.5 $ 338,547 $ 366,886 $ (28,339) (7.7) NET INCOME PER DILUTED SHARE $ 5.06 $ 4.17 $ 0.89 21.3 $ 6.11 $ 6.63 $ (0.52) (7.8) OPERATING INCOME (1) $ 213,687 $ 140,444 $ 73,243 52.2 $ 234,859 $ 244,013 $ (9,154) (3.8) OPERATING INCOME PER DILUTED SHARE (1) $ 3.86 $ 2.54 $ 1.32 52.0 $ 4.24 $ 4.41 $ (0.17) (3.9) CATASTROPHE LOSSES NET OF REINSURANCE (4) $ 29,000 $ 39,000 $ (10,000) (25.6) $ 489,000 $ 236,000 $ 253,000 107.2 COMBINED RATIO (5) 87.0 % 93.6 % — (6.6) PTS 99.0 % 97.6 % — 1.4 PTS (1) THESE MEASURES ARE NOT BASED ON U.S. GENERALLY ACCEPTED ACCOUNTING PRINCIPLES ("GAAP"), ARE DEFINED IN "INFORMATION REGARDING GAAP AND NON-GAAP MEASURES" AND ARE RECONCILED TO THE MOST DIRECTLY COMPARABLE GAAP MEASURES IN "SUPPLEMENTAL SCHEDULES." (2) BOTH NET PREMIUMS EARNED AND NET PREMIUMS WRITTEN FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2025 INCLUDE $101 MILLION OF INCREASED CEDED PREMIUMS DUE TO THE REINSTATEMENT PREMIUMS PAID AND RECORDED IN THE FIRST HALF OF 2025 TO REINSTATE THE FULLY EXHAUSTED REINSURANCE COVERAGE LAYERS OF ITS CATASTROPHE REINSURANCE TREATY ENDING JUNE 30, 2025 FOLLOWING THE PALISADES AND EATON WILDFIRES IN JANUARY 2025.
NEW YORK , NOV. 4, 2025 /PRNEWSWIRE/ -- MONGODB, INC. (NASDAQ: MDB) WILL REPORT ITS THIRD QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS FOR THE THREE MONTHS ENDED OCTOBER 31, 2025, AFTER THE U.S. FINANCIAL MARKETS CLOSE ON MONDAY, DECEMBER 1, 2025. IN CONJUNCTION WITH THIS ANNOUNCEMENT, MONGODB WILL HOST A CONFERENCE CALL ON MONDAY, DECEMBER 1, 2025, AT 5:00 P.M.
ST. PETERSBURG, FLA. , NOV. 4, 2025 /PRNEWSWIRE/ -- NEPTUNE INSURANCE HOLDINGS INC. ("NEPTUNE" OR THE "COMPANY") (NYSE: NP), THE PARENT COMPANY OF NEPTUNE FLOOD INCORPORATED, TODAY ANNOUNCED THAT IT WILL REPORT ITS FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025, AFTER THE MARKET CLOSES ON WEDNESDAY, NOVEMBER 12, 2025.
PURPLE ACHIEVES IMPROVED NET LOSS AND POSITIVE ADJUSTED EBITDA, ADVANCING ITS PROFITABILITY TURNAROUND REJUVENATE 2.0 DRIVES CONTINUED PRODUCT AND BRAND MOMENTUM MATTRESS FIRM ROLLOUT REMAINS ON TRACK, SUPPORTING GROWTH IN PREMIUM SEGMENT LEHI, UTAH , NOV. 4, 2025 /PRNEWSWIRE/ -- PURPLE INNOVATION, INC. (NASDAQ: PRPL) ("PURPLE"), A COMFORT INNOVATION COMPANY WHOSE MATTRESSES PROMISE TO GIVE YOU "LESS PAIN, BETTER SLEEP," TODAY ANNOUNCED RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025. "OUR THIRD QUARTER RESULTS REFLECT THE CONTINUED PROGRESS WE'RE MAKING IN STRENGTHENING PURPLE'S FOUNDATION AND POSITIONING THE COMPANY FOR SUSTAINABLE, PROFITABLE GROWTH," SAID ROB DEMARTINI, CEO OF PURPLE INNOVATION.
REVENUE GROWTH OF 10% YEAR-OVER-YEAR RAISES 2025 REVENUE GUIDANCE TO $665.8-$667.8 MILLION FOSTER CITY, CALIF. , NOV. 4, 2025 /PRNEWSWIRE/ -- QUALYS, INC.
POWERSPORTS RETURNS TO GROWTH CHANDLER, ARIZ. , NOV. 4, 2025 /PRNEWSWIRE/ -- RIDENOW GROUP, INC. (NASDAQ: RDNW), ("WE", "OUR", THE "COMPANY", OR "RIDENOW"), TODAY ANNOUNCED FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025.
NEW YORK , NOV. 4, 2025 /PRNEWSWIRE/ -- SAFEHOLD INC. (NYSE: SAFE), THE CREATOR AND LEADER OF THE MODERN GROUND LEASE INDUSTRY, HAS CLOSED ON GROUND LEASES FOR THE DEVELOPMENT OF SIX AFFORDABLE HOUSING COMMUNITIES IN LOS ANGELES, CALIFORNIA. THE LOW-INCOME TAX CREDIT PROJECTS WILL BE DEVELOPED BY HVN DEVELOPMENT, A NEWLY ESTABLISHED FIRM FOCUSED ON DELIVERING HIGH-QUALITY, EFFICIENTLY DESIGNED AFFORDABLE HOUSING IN INFILL LOCATIONS THROUGHOUT SOUTHERN CALIFORNIA.
GRAND RAPIDS, MICH. , NOV. 4, 2025 /PRNEWSWIRE/ -- SHOULDER INNOVATIONS, INC. ("SHOULDER INNOVATIONS") (NYSE: SI), A COMMERCIAL-STAGE MEDICAL TECHNOLOGY COMPANY EXCLUSIVELY FOCUSED ON TRANSFORMING THE SHOULDER SURGICAL CARE MARKET, TODAY ANNOUNCED THAT ROB BALL, CEO, WILL PRESENT AT THE UPCOMING JEFFERIES GLOBAL HEALTHCARE CONFERENCE.
MAUMEE, OHIO , NOV. 4, 2025 /PRNEWSWIRE/ -- THE ANDERSONS, INC. (NASDAQ: ANDE) ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025. THIRD QUARTER HIGHLIGHTS: REPORTED NET INCOME ATTRIBUTABLE TO THE ANDERSONS OF $20 MILLION OR $0.59 PER DILUTED SHARE AND ADJUSTED NET INCOME ATTRIBUTABLE OF $29 MILLION, OR $0.84 PER DILUTED SHARE ADJUSTED EBITDA OF $78 MILLION RENEWABLES REPORTED PRETAX INCOME OF $43 MILLION AND ADJUSTED PRETAX INCOME ATTRIBUTABLE OF $46 MILLION ON STRONG OPERATING PERFORMANCE AND YEAR-TO-DATE 45Z TAX CREDITS AGRIBUSINESS RECORDED PRETAX INCOME OF $1 MILLION AND ADJUSTED PRETAX INCOME ATTRIBUTABLE OF $2 MILLION "THIS QUARTER'S RESULTS INCLUDE 100% OWNERSHIP OF OUR ETHANOL PLANTS FOR AUGUST AND SEPTEMBER AS A RESULT OF THE ACQUISITION WE COMPLETED AT THE END OF JULY.
SAN DIEGO , NOV. 4, 2025 /PRNEWSWIRE/ -- VIKING THERAPEUTICS, INC. ("VIKING") (NASDAQ: VKTX), A CLINICAL-STAGE BIOPHARMACEUTICAL COMPANY FOCUSED ON THE DEVELOPMENT OF NOVEL THERAPIES FOR METABOLIC AND ENDOCRINE DISORDERS, TODAY ANNOUNCED THAT THE COMPANY WILL PARTICIPATE AT TWO UPCOMING INVESTOR CONFERENCES. DETAILS OF THE COMPANY'S PARTICIPATION ARE AS FOLLOWS: STIFEL 2025 HEALTHCARE CONFERENCE DETAILS: VIKING MANAGEMENT WILL PARTICIPATE IN A FIRESIDE CHAT AND IN INVESTOR MEETINGS CONFERENCE DATES: NOVEMBER 11-13, 2025 FIRESIDE CHAT TIME/DATE: 4:40 – 5:10 P.M.
REPORTED THIRD-QUARTER 2025 NET INCOME ATTRIBUTABLE TO LIMITED PARTNERS OF $331.7 MILLION, GENERATING RECORD THIRD-QUARTER ADJUSTED EBITDA(1) OF $633.8 MILLION. REPORTED THIRD-QUARTER 2025 CASH FLOWS PROVIDED BY OPERATING ACTIVITIES OF $570.2 MILLION, GENERATING THIRD-QUARTER FREE CASH FLOW(1) OF $397.4 MILLION.
ADVANCES DIABETES AND OBESITY PROGRAMS WITH ICOVAMENIB DEMONSTRATING DURABLE 52-WEEK PHASE II DATA AND WITH BMF-650, BIOMEA'S NEXT-GENERATION, ORAL SMALL MOLECULE GLUCAGON-LIKE PEPTIDE-1 (“GLP-1”) RECEPTOR AGONIST (“RA”), DOSING ITS FIRST PATIENT IN A PHASE I CLINICAL TRIAL PRESENTED PRECLINICAL ACTIVITY OF ICOVAMENIB IN COMBINATION WITH SEMAGLUTIDE IN TYPE 2 DIABETES (“T2D”) ANIMAL MODEL AT EASD ANNUAL MEETING, DEMONSTRATING ENHANCED GLYCEMIC CONTROL AND BODY WEIGHT REDUCTION WITH PRESERVATION OF LEAN MASS RAISED APPROXIMATELY $68 MILLION IN GROSS PROCEEDS THROUGH TWO PUBLIC OFFERINGS, EXTENDING PROJECTED CASH RUNWAY INTO THE FIRST QUARTER OF 2027 SAN CARLOS, CALIF., NOV. 04, 2025 (GLOBE NEWSWIRE) -- BIOMEA FUSION, INC. (“BIOMEA” OR “BIOMEA FUSION” OR “THE COMPANY”) (NASDAQ: BMEA), A CLINICAL-STAGE DIABETES AND OBESITY COMPANY, TODAY REPORTED ITS FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025, AND PROVIDED A BUSINESS UPDATE.
CAMBRIDGE, MASS., NOV. 04, 2025 (GLOBE NEWSWIRE) -- SPERO THERAPEUTICS , INC. (NASDAQ: SPRO), A CLINICAL-STAGE BIOPHARMACEUTICAL COMPANY, FOCUSED ON IDENTIFYING AND DEVELOPING NOVEL TREATMENTS FOR RARE DISEASES AND MULTI-DRUG RESISTANT (MDR) BACTERIAL INFECTIONS, TODAY ANNOUNCED THAT IT WILL REPORT ITS THIRD QUARTER 2025 FINANCIAL RESULTS AND PROVIDE A BUSINESS UPDATE ON THURSDAY, NOVEMBER 13, AFTER THE MARKET CLOSE.
BOSTON , NOV. 04, 2025 (GLOBE NEWSWIRE) -- AMWELL ® (NYSE: AMWL), A LEADING PROVIDER OF A COMPREHENSIVE SAAS-BASED SOFTWARE PLATFORM FOR TECHNOLOGY-ENABLED HEALTHCARE, TODAY ANNOUNCED FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30. THE COMPANY'S THIRD QUARTER EARNINGS REPORT MAY BE VIEWED AT INVESTORS.AMWELL.COM.
MINNEAPOLIS, NOV. 04, 2025 (GLOBE NEWSWIRE) -- TILE SHOP HOLDINGS, INC. (NASDAQ: TTSH) (THE “COMPANY”), A SPECIALTY RETAILER OF NATURAL STONE, MAN-MADE AND LUXURY VINYL TILES, TODAY ANNOUNCED RESULTS FOR ITS THIRD QUARTER ENDED SEPTEMBER 30, 2025. THIRD QUARTER 2025 SUMMARY NET SALES DECREASED 1.7% COMPARABLE STORE SALES DECREASED 1.4% GROSS MARGIN OF 62.9% NET LOSS OF $1.6 MILLION AND ADJUSTED EBITDA OF $2.0 MILLION NO DEBT OUTSTANDING AND $24.1 MILLION OF CASH AT QUARTER-END MANAGEMENT COMMENTARY – CABELL LOLMAUGH, CEO “UNIT VOLUMES INCREASED MODESTLY DURING THE QUARTER DRIVEN BY THE STEPS WE'VE TAKEN TO EXPAND OUR ASSORTMENT OF ENTRY LEVEL, COMPETITIVELY PRICED PRODUCTS.
DENVER, NOV. 04, 2025 (GLOBE NEWSWIRE) -- INNOVAGE HOLDING CORP. (“INNOVAGE” OR THE “COMPANY”) (NASDAQ: INNV), AN INDUSTRY LEADER IN PROVIDING COMPREHENSIVE HEALTHCARE PROGRAMS TO FRAIL, PREDOMINANTLY DUAL-ELIGIBLE SENIORS THROUGH THE PROGRAM OF ALL-INCLUSIVE CARE FOR THE ELDERLY (PACE), TODAY ANNOUNCED FINANCIAL RESULTS FOR ITS FISCAL FIRST QUARTER ENDED SEPTEMBER 30, 2025. “WE'RE OFF TO A STRONG START IN FISCAL 2026,” SAID PATRICK BLAIR, CEO.
ATHENS, GREECE, NOV. 04, 2025 (GLOBE NEWSWIRE) -- TEN LTD. (NYSE: TEN) (“TEN” OR THE “COMPANY”), A LEADING DIVERSIFIED CRUDE, PRODUCT AND LNG TANKER OPERATOR, TODAY ANNOUNCED THAT ITS BOARD OF DIRECTORS DECLARED THE REGULAR QUARTERLY CASH DIVIDEND OF $0.578125 PER SHARE FOR ITS SERIES E CUMULATIVE PERPETUAL PREFERRED SHARES (THE “SERIES E PREFERRED SHARES”; NYSE; TENPRE).
SOUTH SAN FRANCISCO, CALIF., NOV. 04, 2025 (GLOBE NEWSWIRE) -- RAPT THERAPEUTICS, INC. (NASDAQ: RAPT), A CLINICAL-STAGE IMMUNOLOGY-BASED BIOPHARMACEUTICAL COMPANY FOCUSED ON DISCOVERING, DEVELOPING AND COMMERCIALIZING NOVEL THERAPIES FOR PATIENTS LIVING WITH INFLAMMATORY AND IMMUNOLOGICAL DISEASES, TODAY ANNOUNCED THAT MEMBERS OF THE RAPT MANAGEMENT TEAM WILL PARTICIPATE IN THE FOLLOWING INVESTOR CONFERENCES IN NOVEMBER: GUGGENHEIM'S 2ND ANNUAL HEALTHCARE INNOVATION CONFERENCE – FIRESIDE CHAT ON TUESDAY, NOVEMBER 11, 2025 AT 3:30 P.M.
- NEW CASE STUDIES ON FIRST-LINE PANCREATIC CANCER PATIENTS TREATED WITH ATEBIMETINIB IN COMBINATION WITH FOLFIRINOX TO BE SHARED BY TRIAL INVESTIGATORS – - CONFERENCE CALL SCHEDULED FOR WEDNESDAY, NOVEMBER 12, 2025, AT 4:30 PM ET - NEW YORK, NOV. 04, 2025 (GLOBE NEWSWIRE) -- IMMUNEERING CORPORATION (NASDAQ: IMRX), A CLINICAL-STAGE ONCOLOGY COMPANY FOCUSED ON KEEPING CANCER PATIENTS ALIVE, TODAY ANNOUNCED THAT THE COMPANY WILL REPORT THIRD QUARTER 2025 FINANCIAL RESULTS AND TRIAL INVESTIGATORS WILL PROVIDE CASE STUDIES FROM FIRST-LINE PANCREATIC CANCER PATIENTS TREATED IN THE COMPANY'S PHASE 2A STUDY OF ATEBIMETINIB IN COMBINATION WITH FOLFIRINOX, ON WEDNESDAY, NOVEMBER 12, 2025, AFTER THE CLOSE OF MARKET. IMMUNEERING WILL HOST A CONFERENCE CALL AND WEBCAST AT 1:30 PM PT / 4:30 PM ET ON THE SAME DAY.
MEETS OR EXCEEDS ALL THIRD QUARTER GUIDANCE METRICS GAAP NET INCOME OF $5.2 MILLION REFLECTS $35 MILLION YEAR-OVER-YEAR IMPROVEMENT GAAP EPS OF $0.11 , UP $0.86 VERSUS PRIOR-YEAR PERIOD ADJUSTED EPS OF $0.39 , UP SHARPLY VERSUS $0.02 IN 3Q24 OPERATING EXPENSES REDUCED 11% YEAR-OVER-YEAR, SUPPORTING CONTINUED MARGIN EXPANSION SAN CARLOS, CALIF., NOV. 04, 2025 (GLOBE NEWSWIRE) -- OPORTUN FINANCIAL CORPORATION (NASDAQ: OPRT) (“OPORTUN”, OR THE "COMPANY") TODAY REPORTED FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025.
SAN FRANCISCO, NOV. 04, 2025 (GLOBE NEWSWIRE) -- LIVERAMP® (NYSE: RAMP), A LEADING DATA COLLABORATION PLATFORM, TODAY ANNOUNCED THAT ITS CFO LAUREN DILLARD WILL PRESENT AT THE WELLS FARGO 9TH ANNUAL TMT SUMMIT IN RANCHO PALOS VERDES, CA ON TUESDAY, NOVEMBER 18TH AT 12:45 P.M. PT / 3:45 P.M.
MIAMI, NOV. 04, 2025 (GLOBE NEWSWIRE) -- PENNANTPARK FLOATING RATE CAPITAL LTD. (THE "COMPANY") (NYSE: PFLT) DECLARES ITS MONTHLY DISTRIBUTION FOR NOVEMBER 2025 OF $0.1025 PER SHARE, PAYABLE ON DECEMBER 1, 2025 TO STOCKHOLDERS OF RECORD AS OF NOVEMBER 17, 2025.
BUSINESS HIGHLIGHTS: GENERATES THIRD QUARTER YEAR-TO-DATE POSITIVE ADJUSTED EBITDA PROFITABILITY, ON A WIDE NETWORK, WHILE GROWING MEMBERSHIP BY 35% AND REVENUE BY 39% YEAR-OVER-YEAR, DESPITE A GREATER PROPORTION OF NEW MEMBERS RELATIVE TO RETURNING MEMBER BASE HIGH COVERAGE OF CLOVER ASSISTANT, INCLUDING WITHIN NEW COHORTS, WILL RESULT IN IMPROVED TOTAL COST OF CARE STRONG RETENTION, ABOVE-MARKET GROWTH, AND PROFITABLE RETURNING MEMBER COHORTS POSITION CLOVER FOR IMPROVED POSITIVE FY26 FINANCIAL RESULTS FINANCIAL RESULTS: THIRD QUARTER 2025 MEDICARE ADVANTAGE MEMBERSHIP OF 109,226, UP 35% YEAR-OVER-YEAR THIRD QUARTER 2025 TOTAL REVENUES OF $497 MILLION, UP 50% YEAR-OVER-YEAR THIRD QUARTER 2025 PROFITABILITY METRICS INCLUDE GAAP NET LOSS OF $24 MILLION, ADJUSTED EBITDA OF $2 MILLION, AND ADJUSTED NET INCOME OF $2 MILLION THIRD QUARTER YEAR-TO-DATE GAAP NET LOSS OF $36 MILLION , ADJUSTED EBITDA OF $45 MILLION , AND ADJUSTED NET INCOME OF $44 MILLION REVISED FULL YEAR 2025 GUIDANCE: INCREASES AVERAGE MEDICARE ADVANTAGE MEMBERSHIP TO 106,000 - 108,000, REPRESENTING 33% GROWTH YEAR-OVER-YEAR AT THE MIDPOINT INCREASES INSURANCE REVENUE TO BETWEEN $1.850 BILLION AND $1.880 BILLION, REPRESENTING 39% GROWTH YEAR-OVER-YEAR AT THE MIDPOINT IMPROVES ADJUSTED SG&A TO BETWEEN $325 MILLION AND $335 MILLION, REPRESENTING ADJUSTED SG&A AS A PERCENTAGE OF TOTAL REVENUES BETWEEN 17% - 18% EXPECTS ADJUSTED EBITDA PROFITABILITY BETWEEN $15 MILLION AND $30 MILLION EXPECTS ADJUSTED NET INCOME BETWEEN $15 MILLION AND $30 MILLION EXPECTS INSURANCE BER BETWEEN 90% - 91% DIRECTIONAL FULL YEAR 2026 OUTLOOK: COMPANY INTENDS TO MAINTAIN STRONG, SUSTAINABLE GROWTH, SIMILAR TO 2025 STRONG START TO AEP WITH HIGH APPLICATIONS IN CORE MARKETS. HIGH EXPECTED RETENTION EXPECT STRONG RETURNING MEMBER COHORT ECONOMICS, 4.0 STAR PAYMENT YEAR, FAVORABLE CMS RATE UPDATE, INCREASED PART D DIRECT SUBSIDY WILL ENABLE INCREASING ADJUSTED EBITDA PROFITABILITY WILMINGTON, DEL.
BETHESDA, MD.--(BUSINESS WIRE)--GLOBAL MEDICAL REIT INC. (NYSE: GMRE) (THE “COMPANY” OR “GMRE”), TODAY ANNOUNCED FINANCIAL RESULTS FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2025 AND OTHER DATA. NOTE: ALL SHARE AND PER SHARE DATA HAVE BEEN ADJUSTED FOR ALL PERIODS PRESENTED TO REFLECT THE COMPANY'S ONE-FOR-FIVE REVERSE STOCK SPLIT THAT WAS EFFECTIVE SEPTEMBER 19, 2025. THIRD QUARTER 2025 AND OTHER HIGHLIGHTS NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS WAS $6.0 MILLION, OR $0.45 PER DILU.
BOTHELL, WASH.--(BUSINESS WIRE)--IMMUNOME, INC. (THE “COMPANY”) (NASDAQ: IMNM), A BIOTECHNOLOGY COMPANY FOCUSED ON DEVELOPING FIRST-IN-CLASS AND BEST-IN-CLASS TARGETED CANCER THERAPIES, ANNOUNCED TODAY THAT ON NOV. 3, 2025, THE COMPENSATION COMMITTEE OF THE COMPANY'S BOARD OF DIRECTORS (THE “COMPENSATION COMMITTEE”) GRANTED INDUCEMENT AWARDS CONSISTING OF NONSTATUTORY STOCK OPTIONS TO PURCHASE AN AGGREGATE OF 19,000 SHARES OF COMMON STOCK TO THREE NEW EMPLOYEES UNDER THE COMPANY'S 2024 INDUCEME.
BURBANK, CALIF.--(BUSINESS WIRE)--ENTRAVISION COMMUNICATIONS CORPORATION (NYSE: EVC), A MEDIA AND ADVERTISING TECHNOLOGY COMPANY, TODAY ANNOUNCED FINANCIAL RESULTS FOR ITS THIRD QUARTER ENDED SEPTEMBER 30, 2025. “OUR MEDIA SEGMENT NET REVENUE DECLINED 26% IN THE THIRD QUARTER OF 2025 YEAR-OVER-YEAR, PRIMARILY DUE TO LOWER POLITICAL REVENUE AND WEAKER REVENUE FROM NATIONAL TELEVISION AND RADIO ADVERTISERS. AVERAGE MONTHLY ADVERTISERS AND REVENUE PER AVERAGE MONTHLY ADVERTISER FOR OUR LOCAL MEDIA.
EMERYVILLE, CALIF.--(BUSINESS WIRE)---- $OABI #OABI--OMNIAB, INC. (NASDAQ: OABI) TODAY REPORTED FINANCIAL RESULTS FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2025, AND PROVIDED OPERATING AND PARTNER PROGRAM UPDATES. “THROUGHOUT THE THIRD QUARTER WE CONTINUED TO EXECUTE ON OUR STRATEGIC INITIATIVES WHILE FURTHER DEMONSTRATING THE VALUE OF OUR PROPRIETARY TECHNOLOGY PLATFORM TO A GROWING BASE OF PARTNERS. THE NUMBER OF NEW PROGRAM ADDITIONS SO FAR THIS YEAR HAS SIGNIFICANTLY OUTPACED LAST YEAR, BOLSTERING.
SANTA MONICA, CALIF.--(BUSINESS WIRE)--GOODRX HOLDINGS, INC. (NASDAQ: GDRX) ("WE," "US," "OUR," “GOODRX,” OR THE “COMPANY”), THE LEADING PLATFORM FOR MEDICATION SAVINGS IN THE U.S., HAS RELEASED ITS FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2025. THIRD QUARTER 2025 HIGHLIGHTS REVENUE OF $196.0 MILLION NET INCOME OF $1.1 MILLION; NET INCOME MARGIN OF 0.6% ADJUSTED NET INCOME1 OF $28.8 MILLION; ADJUSTED NET INCOME MARGIN1 OF 14.7% ADJUSTED EBITDA1 OF $66.3 MILLION; ADJUSTED EBITDA MARGIN1 OF 33.
MAHWAH, N.J.--(BUSINESS WIRE)--KORU MEDICAL SYSTEMS, INC. (NASDAQ: KRMD) (“KORU MEDICAL” OR THE “COMPANY”), A LEADING MEDICAL TECHNOLOGY COMPANY FOCUSED ON THE DEVELOPMENT, MANUFACTURING, AND COMMERCIALIZATION OF INNOVATIVE AND EASY-TO-USE PATIENT-CENTRIC LARGE VOLUME SUBCUTANEOUS INFUSION SOLUTIONS, TODAY ANNOUNCED A DEVELOPMENT AGREEMENT WITH A GLOBAL PHARMACEUTICAL COMPANY. THE AGREEMENT ALLOWS FOR BROAD COLLABORATION ON NEXT-GENERATION INFUSION SYSTEMS IN SUBCUTANEOUS IMMUNOGLOBULIN (SCIG).
BRISBANE, CALIF.--(BUSINESS WIRE)--CAREDX, INC. (NASDAQ: CDNA) — THE TRANSPLANT COMPANY — A LEADING PRECISION MEDICINE COMPANY FOCUSED ON THE DISCOVERY, DEVELOPMENT AND COMMERCIALIZATION OF CLINICALLY DIFFERENTIATED, HIGH-VALUE HEALTHCARE SOLUTIONS FOR TRANSPLANT PATIENTS AND CAREGIVERS, TODAY REPORTED FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025. THIRD QUARTER 2025 FINANCIAL HIGHLIGHTS REVENUE OF $100.1 MILLION, AN INCREASE OF 21% YEAR-OVER-YEAR TESTING SERVICES REVENUE OF.
RICHMOND, VA.--(BUSINESS WIRE)--LUCKY STRIKE ENTERTAINMENT TODAY PROVIDED FINANCIAL RESULTS FOR THE FIRST QUARTER OF THE 2026 FISCAL YEAR, WHICH ENDED ON SEPTEMBER 28, 2025.
NEW YORK--(BUSINESS WIRE)--MNTN (NYSE: MNTN), A TECHNOLOGY PLATFORM THAT BRINGS PERFORMANCE MARKETING TO CONNECTED TV, TODAY ANNOUNCED ITS OPERATIONAL AND FINANCIAL RESULTS FOR THE THIRD QUARTER, ENDED SEPTEMBER 30, 2025. MNTN IS REDEFINING HOW BRANDS USE TELEVISION - MAKING TV ADVERTISING AS MEASURABLE, PRECISE, AND PERFORMANCE-DRIVEN AS SEARCH AND SOCIAL. MNTN'S SOFTWARE IS UNLOCKING TELEVISION FOR MILLIONS OF SMALL TO MIDSIZED BUSINESSES, ALLOWING THEM TO TURN CONNECTED TV INTO A CORE PART O.
ALAMEDA, CALIF.--(BUSINESS WIRE)--EXELIXIS, INC. (NASDAQ: EXEL) TODAY REPORTED FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2025, PROVIDED AN UPDATE ON PROGRESS TOWARD ACHIEVING KEY CORPORATE OBJECTIVES, AND OUTLINED ITS COMMERCIAL, CLINICAL AND PIPELINE DEVELOPMENT MILESTONES. “IN THE THIRD QUARTER OF 2025, EXELIXIS GAINED MOMENTUM IN THE CABOZANTINIB FRANCHISE AND DELIVERED ON CRITICAL STRATEGIC PRIORITIES ACROSS THE RESEARCH & DEVELOPMENT PORTFOLIO,” SAID MICHAEL M. MORRISSEY, PH.D., PRESI.
SAN FRANCISCO--(BUSINESS WIRE)--HINGE HEALTH, INC. (NYSE: HNGE) TODAY ANNOUNCED FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025. “WITH HEALTHCARE COSTS RISING DRAMATICALLY, OUR MISSION TO AUTOMATE CARE DELIVERY HAS NEVER BEEN MORE URGENT,” SAID DANIEL PEREZ, CO-FOUNDER AND CEO, HINGE HEALTH. “THIS QUARTER WE SURPASSED 1.5 MILLION LIFETIME MEMBERS, DELIVERED YEAR-OVER-YEAR REVENUE GROWTH OF 53%, AND GENERATED RECORD FREE CASH FLOW. OUR AI-POWERED PLATFORM IS TRANSFORMING CARE AT.
LEANDER, TEXAS, NOV. 04, 2025 (GLOBE NEWSWIRE) -- TOLL BROTHERS, INC. (NYSE:TOL), THE NATION'S LEADING BUILDER OF LUXURY HOMES, TODAY ANNOUNCED THE OPENING OF ITS NEWEST COMMUNITY, WILDSPRING BY TOLL BROTHERS, IN LEANDER, TEXAS. THIS NEW COMMUNITY FEATURES TWO COLLECTIONS OF THOUGHTFULLY DESIGNED SINGLE-FAMILY HOMES WITH OUTSTANDING PERSONALIZATION OPTIONS, SITUATED WITHIN THE HIGHLY RATED LEANDER INDEPENDENT SCHOOL DISTRICT.
LITTLE ROCK, ARK.--(BUSINESS WIRE)--MONTROSE ENVIRONMENTAL GROUP, INC. (THE “COMPANY,” “MONTROSE” OR “MEG”) (NYSE: MEG) IS ON A MISSION TO HELP PROTECT THE AIR WE BREATHE, THE WATER WE DRINK, AND THE SOIL THAT SUSTAINS US TO ENHANCE ENVIRONMENTAL STEWARDSHIP WHILE SUPPORTING ECONOMIC DEVELOPMENT. TODAY, THE COMPANY ANNOUNCED RESULTS FOR THE THIRD QUARTER AND FIRST NINE-MONTH PERIODS ENDED SEPTEMBER 30, 2025. MONTROSE CHIEF EXECUTIVE OFFICER AND DIRECTOR, VIJAY MANTHRIPRAGADA, COMMENTED, “I AM T.
IRVINE, CALIF.--(BUSINESS WIRE)--RIVIAN AUTOMOTIVE, INC. (NASDAQ: RIVN), AN AMERICAN AUTOMOTIVE MANUFACTURER THAT DEVELOPS AND BUILDS CATEGORY-DEFINING ELECTRIC VEHICLES AS WELL AS SOFTWARE AND SERVICES THAT ADDRESS THE ENTIRE LIFECYCLE OF THE VEHICLE, TODAY ANNOUNCED ITS THIRD-QUARTER 2025 FINANCIAL RESULTS. RJ SCARINGE, RIVIAN FOUNDER AND CEO, SAID: “IN Q3, WE CONTINUED TO MAKE SIGNIFICANT PROGRESS ACROSS OUR STRATEGIC PRIORITIES WHICH INCLUDES R2 AND OUR TECHNOLOGY ROADMAP. R2 DELIVERS ON TH.
SAN JOSE, CALIF.--(BUSINESS WIRE)--LUMENTUM HOLDINGS INC. (“LUMENTUM” OR THE “COMPANY”) TODAY REPORTED RESULTS FOR ITS FISCAL FIRST QUARTER ENDED SEPTEMBER 27, 2025. “IN OUR FISCAL FIRST QUARTER, WE SAW YEAR-OVER-YEAR REVENUE GROWTH OF 58 PERCENT AND OPERATING MARGIN EXPANSION OF OVER 1,500 BASIS POINTS ON A NON-GAAP BASIS. REVENUE, OPERATING MARGIN, AND EARNINGS PER SHARE ALL CAME IN AT THE HIGH END OF OUR GUIDANCE RANGES,” SAID MICHAEL HURLSTON, LUMENTUM PRESIDENT AND CEO. “OUR FIRST-QUARTER.
SEQUENTIAL QUARTERLY INCREASE IN GROSS MARGINS; CONTINUED PROGRAM WINS; POSITIVE CASH FLOW FROM OPERATIONS
CORAL GABLES, FLA., NOV. 04, 2025 (GLOBE NEWSWIRE) -- CATALYST PHARMACEUTICALS, INC. ("CATALYST" OR "COMPANY") (NASDAQ: CPRX), A COMMERCIAL-STAGE BIOPHARMACEUTICAL COMPANY FOCUSED ON IN-LICENSING, DEVELOPING, AND COMMERCIALIZING NOVEL MEDICINES FOR PATIENTS LIVING WITH RARE AND DIFFICULT-TO-TREAT DISEASES, TODAY ANNOUNCED THAT IT HAS BEEN NAMED AS ONE OF THE BIOSPACE 2026 BEST PLACES TO WORK FOR THE SECOND CONSECUTIVE YEAR, RANKING 13 AMONG 30 U.S. EMPLOYERS IN THE SMALL COMPANY CATEGORY.
SAN JOSE, CALIF., NOV. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BIOROBOTICS® CORPORATION (NASDAQ: PRCT) (THE “COMPANY”), A SURGICAL ROBOTICS COMPANY FOCUSED ON ADVANCING PATIENT CARE BY DEVELOPING TRANSFORMATIVE SOLUTIONS IN UROLOGY, TODAY REPORTED UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED SEPTEMBER 30, 2025.
DENVER, NOV. 04, 2025 (GLOBE NEWSWIRE) -- JOHNSON FISTEL, PLLP ANNOUNCES THAT A CLASS ACTION LAWSUIT HAS COMMENCED ON BEHALF OF INVESTORS OF LANTHEUS HOLDINGS, INC. (NASDAQ: LNTH). THE LAWSUIT SEEKS TO RECOVER LOSSES ON BEHALF OF INVESTORS WHO PURCHASED THE COMPANY'S SECURITIES BETWEEN FEBRUARY 26, 2025 AND AUGUST 5, 2025, INCLUSIVE (THE “CLASS PERIOD”).
LOS ANGELES , NOV. 4, 2025 /PRNEWSWIRE/ -- REVOLVE GROUP, INC. (NYSE: RVLV), THE NEXT-GENERATION FASHION RETAILER FOR MILLENNIAL AND GENERATION Z CONSUMERS, TODAY ANNOUNCED FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025. THIRD QUARTER 2025 FINANCIAL SUMMARY THREE MONTHS ENDED SEPTEMBER 30, 2025 2024 YOY CHANGE (IN THOUSANDS, EXCEPT PERCENTAGES) NET SALES $ 295,631 $ 283,146 4 % GROSS PROFIT $ 161,516 $ 144,867 11 % GROSS MARGIN 54.6 % 51.2 % NET INCOME $ 21,179 $ 10,751 97 % ADJUSTED EBITDA (NON-GAAP FINANCIAL MEASURE) $ 25,347 $ 17,503 45 % NET CASH PROVIDED BY OPERATING ACTIVITIES $ 11,818 $ 9,052 31 % FREE CASH FLOW (NON-GAAP FINANCIAL MEASURE) $ 6,627 $ 6,171 7 % OPERATIONAL METRICS THREE MONTHS ENDED SEPTEMBER 30, 2025 2024 YOY CHANGE (IN THOUSANDS, EXCEPT AVERAGE ORDER VALUE AND PERCENTAGES) ACTIVE CUSTOMERS (TRAILING 12 MONTHS) 2,747 2,628 5 % TOTAL ORDERS PLACED 2,300 2,200 5 % AVERAGE ORDER VALUE $ 306 $ 303 1 % "WE HAD A VERY SOLID THIRD QUARTER, HIGHLIGHTED BY EXCEPTIONAL GROSS MARGIN PERFORMANCE THAT DROVE AN 11% INCREASE IN GROSS PROFIT YEAR-OVER-YEAR AND A 45% INCREASE IN ADJUSTED EBITDA TO $25 MILLION, OUR HIGHEST EVER FOR A THIRD QUARTER," SAID CO-FOUNDER AND CO-CEO MIKE KARANIKOLAS.